Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures

Journal of Interventional Cardiology

Volumn 25, Issue 4, 2012, Pages 404-410

  Bilasy, Mohammed Elshawadfy M ^a   Oraby, Mohammed A ^a   Ismail, Hussein M ^a   Maklady, Fathi A ^a  

^a Suez Canal University Faculty of Medicine   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CREATININE; FARCOPHYLLINE; IOPAMIDOL; PLACEBO; SCANLUX; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADULT; ANEMIA; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYDRATION; INCIDENCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCORING SYSTEM; SINGLE BLIND PROCEDURE;

ACETYLCYSTEINE; ADULT; AGED; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; MIDDLE AGED; RISK ASSESSMENT; SINGLE-BLIND METHOD; SODIUM CHLORIDE; THEOPHYLLINE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84864622592     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2012.00730.x     Document Type: Article

References (38)

1. Hou SH, Bushinsky DA, Wish JB, et al,. Hospital acquired renal insufficiency. A prospective study. Am J Med 1983; 74: 243-248. (Pubitemid 13192180)
2. Morcos SK,. Contrast media-induced nephrotoxicity-questions and answers. Br J Radiol 1998; 71: 357-365.
3. Rich MW, Crecelius CA,. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 1990; 150: 1237-1242. (Pubitemid 20188457)
4. McCullough PA, Wolyn R, Rocher LL, et al,. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-375. (Pubitemid 27506242)
5. Levy EM, Viscoli CM, Horwitz RI,. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996; 275: 1489-1494. (Pubitemid 26140761)
6. Rihal CS, Textor SC, Grill DE, et al., Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264. (Pubitemid 34535335)
7. Aronow HD, Peyser PA, Eagle KA, et al,. Predictors of length of stay after coronary stenting. Am Heart J 2001; 142: 799-805. (Pubitemid 33016196)
8. Morcos SK, Thomsen HS,. European Society of Urogenital Radiology. European Society of Urogenital Radiology guidelines on administering contrast media. Abdom Imaging 2003; 28: 187-190. (Pubitemid 36459324)
9. Gami AS, Garovic VD,. Contrast nephropathy after coronary angiography. Mayo Clin Proc 2004; 79: 211-219. (Pubitemid 38140805)
10. Maeder M, Klein M, Fehr T, et al,. Contrast nephropathy: Review focusing on prevention. J Am Coll Cardiol 2004; 44: 1763-1771. (Pubitemid 39424073)
11. Idé JM, Lancelot E, Pines E, et al,. Prophylaxis of iodinated contrast media-induced nephropathy: A pharmacological point of view. Invest Radiol 2004; 39: 155-170. (Pubitemid 38263922)
12. Lin J, Bonventre JV,. Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hypertens 2005; 14: 105-110. (Pubitemid 40396862)
13. Asif A, Epstein M,. Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 2004; 44: 12-24. (Pubitemid 38880922)
14. Caldicott WJ, Hollenberg NK, Abrams HL,. Characteristics of response of renal vascular bed to contrast media. Evidence for vasoconstriction induced by renin-angiotensin system. Invest Radiol 1970; 5: 539-547.
15. Katzberg RW, Morris TW, Burgener FA, et al,. Renal renin and hemodynamic responses to selective renal artery catheterization and angiography. Invest Radiol 1977; 12: 381-388. (Pubitemid 8221100)
16. Mehran R, Aymong ED, Nikolsky E, et al,. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399. (Pubitemid 39303939)
17. Freeman RV, O'Donnell M, Share D, et al,. For the Blue Cross-Blue Shield of Michigan Cardiovascular Consortium (BMC2). Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002; 90: 1068-1073. (Pubitemid 35335595)
18. Cigarroa RG, Lange RA, Williams RH, et al,. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989; 86: 649-652. (Pubitemid 19149343)
19. Kapoor A, Kumar S, Gulati S, et al,. The role of theophylline in contrast-induced nephropathy, a case-control study. Nephrol Dial Transplant 2002; 17: 1936-1947
20. Abizaid AS, Clark CE, Mintz GS, et al,. Effects of dopamine and aminophylline on contrast induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am J Cardiol 1999; 83: 260-263. (Pubitemid 29047309)
21. Erley CM, Duda SH, Schlepckow S, et al,. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int 1994; 45: 1425-1431. (Pubitemid 24135030)
22. Katholi RE, Taylor GJ, McCann WP, et al,. Nephrotoxicity from contrast media: Attenuation with theophylline. Radiology 1995; 195: 17-22.
23. Kolonko A, Wiecek A, Kokot F,. The nonselective adenosine antagonist theophylline does prevent renal dysfunction induced by radiographic contrast agents. J Nephrol 1998; 11: 151-156. (Pubitemid 28288221)
24. Huber W, Ilgmann K, Page M, et al,. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: Controlled, randomized, double-blinded study. Radiology 2002; 223: 772-779. (Pubitemid 34547597)
25. Huber W, Schipek C, Ilgmann K, et al,. Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency. Am J Cardiol 2003; 91: 1157-1162. (Pubitemid 36561376)
26. Erley CM, Duda SH, Rehfuss D, et al,. Prevention of radiocontrast-media- induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant 1999; 14: 1146-1149. (Pubitemid 29209299)
27. Huber W, Jeschke B, Page M, et al,. Reduced incidence of radiocontrast-induced nephropathy in ICU patients under theophylline prophylaxis: A prospective comparison to series of patients at similar risk. Intensive Care Med 2001; 27: 1200-1209. (Pubitemid 32710208)
28. Huber W, Eckel F, Hennig M, et al,. Prophylaxis of contrast material-induced nephropathy in patients in intensive care: Acetylcysteine, theophylline, or both? A randomized study. Radiology 2006; 239: 793-804. (Pubitemid 43830615)
29. Tepel M, Van Der Giet M, Schwarzfeld C, et al,. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-184. (Pubitemid 30489215)
30. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW,. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 2002; 89: 356-358. (Pubitemid 34113804)
31. Kay J, Chow WH, Chan TM, et al,. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: A randomized controlled trial. JAMA 2003; 289: 553-558. (Pubitemid 37428626)
32. Arakawa K, Suzuki H, Naith M, et al,. Role of adenosine in the renal responses to contrast medium. Kidney Int 1996; 49: 1199-1206. (Pubitemid 26167274)
33. Olroyd SD, Fang L, Hyalor JL, et al,. Effects of adenosine receptor antagonists on the responses to contrast media in the isolated rat kidney. Clin Sci (Lond) 2000; 98: 303-311. (Pubitemid 30145237)
34. Pflueger AC, Schenk F, Osswald H,. Increased sensitivity of the renal vasculature to adenosine in streptozotocin-induced diabetes mellitus in rats. Am J Physiol 1995; 269: F529-F535.
35. Maioli M, Toso A, Leoncini M, et al,. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 2008; 52: 599-604.
36. Barrett BJ, Parfrey PS,. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 1994; 331: 1449-1450. (Pubitemid 24348362)
37. Idé JM, Beaufiles H, Bonnemain B,. Iodinated contrast media-induced nephropathy: Pathophysiology, clinical aspects and prevention. Fundam Clin Pharmacol 1994; 8: 193-206 (Pubitemid 24182383)
38. Porter GA,. Radiocontrast-induced nephropathy. Nephrol Dial Transpl 1994; 9: 146-156. (Pubitemid 24249490)